tiprankstipranks
Trending News
More News >
Athira Pharma (ATHA)
NASDAQ:ATHA
US Market

Athira Pharma (ATHA) Financial Statements

Compare
567 Followers

Athira Pharma Financial Overview

Athira Pharma's market cap is currently $25.83M. The company's EPS TTM is $-1.68; its P/E ratio is -0.68; Athira Pharma is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -479.00K$ -2.00M
Operating Income$ -100.90M$ -125.47M$ -104.02M$ -64.02M$ -20.00M
EBITDA$ -95.81M$ -125.97M$ -88.01M$ -54.37M$ -19.59M
Net Income$ -96.94M$ -117.67M$ -95.64M$ -54.85M$ -19.95M
Balance Sheet
Cash & Short-Term Investments$ 51.27M$ 147.42M$ 200.34M$ 253.76M$ 184.68M
Total Assets$ 58.78M$ 160.25M$ 258.15M$ 332.01M$ 279.56M
Total Debt$ 1.22M$ 1.58M$ 1.91M$ 1.92M$ 1.00M
Net Debt$ -47.22M$ -89.00M$ -94.06M$ -108.62M$ -59.63M
Total Liabilities$ 13.94M$ 30.06M$ 23.02M$ 10.92M$ 5.28M
Stockholders' Equity$ 44.84M$ 130.19M$ 235.14M$ 321.08M$ 274.28M
Cash Flow
Free Cash Flow$ -97.20M$ -101.06M$ -73.61M$ -44.67M$ -26.43M
Operating Cash Flow$ -97.17M$ -100.75M$ -72.47M$ -43.10M$ -24.11M
Investing Cash Flow$ 54.83M$ 95.09M$ 57.66M$ -4.08M$ -210.07M
Financing Cash Flow$ 194.00K$ 493.00K$ 654.00K$ 97.09M$ 292.75M
Currency in USD

Athira Pharma Earnings and Revenue History

Athira Pharma Debt to Assets

Athira Pharma Cash Flow

Athira Pharma Forecast EPS vs Actual EPS